A Study of the Effect of LY2216684 on Lorazepam

NCT01275144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Placebo
DRUG: Lorazepam

Sponsor

Eli Lilly and Company